Moloudi, K.; Sangsuwan, T.; Monzen, S.; Fujishima, Y.; Anderson, D.; Frey, B.; Miura, T.; Azariasl, S.; Yasuda, H.; Haghdoost, S.
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) as a Biomarker for Radiation Dosimetry and Health Risk Assessment: A Review. Antioxidants 2025, 14, 1393.
https://doi.org/10.3390/antiox14121393
AMA Style
Moloudi K, Sangsuwan T, Monzen S, Fujishima Y, Anderson D, Frey B, Miura T, Azariasl S, Yasuda H, Haghdoost S.
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) as a Biomarker for Radiation Dosimetry and Health Risk Assessment: A Review. Antioxidants. 2025; 14(12):1393.
https://doi.org/10.3390/antiox14121393
Chicago/Turabian Style
Moloudi, Kave, Traimate Sangsuwan, Satoru Monzen, Yohei Fujishima, Donovan Anderson, Benjamin Frey, Tomisato Miura, Samayeh Azariasl, Hiroshi Yasuda, and Siamak Haghdoost.
2025. "Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) as a Biomarker for Radiation Dosimetry and Health Risk Assessment: A Review" Antioxidants 14, no. 12: 1393.
https://doi.org/10.3390/antiox14121393
APA Style
Moloudi, K., Sangsuwan, T., Monzen, S., Fujishima, Y., Anderson, D., Frey, B., Miura, T., Azariasl, S., Yasuda, H., & Haghdoost, S.
(2025). Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) as a Biomarker for Radiation Dosimetry and Health Risk Assessment: A Review. Antioxidants, 14(12), 1393.
https://doi.org/10.3390/antiox14121393
